Brief: Xeris Biopharma Reports Third Quarter 2023 Financial Results
09/11/2023 12:30
Nov 9 (Reuters) - Xeris Biopharma Holdings Inc XERS.O :
* XERIS BIOPHARMA REPORTS THIRD QUARTER 2023 FINANCIAL
RESULTS
* XERIS BIOPHARMA HOLDINGS INC - TIGHTENS FULL-YEAR 2023
REVENUE
GUIDANCE FROM $155M-$165M TO $160M-$165M
* XERIS BIOPHARMA HOLDINGS INC - CONFIDENT WE WILL ACHIEVE
CASH
FLOW BREAKEVEN IN Q4
Source text for Eikon: ID:nBw1Jy0Mpa
Further company coverage: XERS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest